Join
Live feed
·
INSIDERFilingvia Quantisnow
Monte Rosa Therapeutics Inc. logo

Director Behbahani Ali disposed of 1,015,000 shares and acquired 15,000 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
GLUE· Monte Rosa Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GLUE (Monte Rosa Therapeutics Inc.) and more on Quantisnow.